- Home
- LQDT vs IMTX Comparison
LQDT vs IMTX Comparison
Compare LQDT & IMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LQDT
- IMTX
- Stock Information
- Founded
- LQDT 1999
- IMTX N/A
- Country
- LQDT United States
- IMTX Germany
- Employees
- LQDT N/A
- IMTX N/A
- Industry
- LQDT Catalog/Specialty Distribution
- IMTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- LQDT Consumer Discretionary
- IMTX Health Care
- Exchange
- LQDT Nasdaq
- IMTX Nasdaq
- Market Cap
- LQDT 805.9M
- IMTX 653.9M
- IPO Year
- LQDT 2006
- IMTX N/A
- Fundamental
- Price
- LQDT $26.77
- IMTX $6.26
- Analyst Decision
- LQDT Strong Buy
- IMTX Strong Buy
- Analyst Count
- LQDT 2
- IMTX 4
- Target Price
- LQDT $38.50
- IMTX $14.67
- AVG Volume (30 Days)
- LQDT 275.4K
- IMTX 984.5K
- Earning Date
- LQDT 08-07-2025
- IMTX 08-13-2025
- Dividend Yield
- LQDT N/A
- IMTX N/A
- EPS Growth
- LQDT 33.77
- IMTX N/A
- EPS
- LQDT 0.83
- IMTX N/A
- Revenue
- LQDT $465,508,000.00
- IMTX $152,823,253.00
- Revenue This Year
- LQDT $31.57
- IMTX N/A
- Revenue Next Year
- LQDT $2.58
- IMTX N/A
- P/E Ratio
- LQDT $32.25
- IMTX N/A
- Revenue Growth
- LQDT 38.40
- IMTX 83.61
- 52 Week Low
- LQDT $21.02
- IMTX $3.30
- 52 Week High
- LQDT $39.72
- IMTX $13.09
- Technical
- Relative Strength Index (RSI)
- LQDT 59.15
- IMTX 58.89
- Support Level
- LQDT $25.80
- IMTX $5.29
- Resistance Level
- LQDT $26.63
- IMTX $5.56
- Average True Range (ATR)
- LQDT 0.66
- IMTX 0.35
- MACD
- LQDT 0.03
- IMTX 0.04
- Stochastic Oscillator
- LQDT 67.23
- IMTX 85.03
About LQDT Liquidity Services Inc.
Liquidity Services Inc is an online auction marketplace. It manages and sells inventory and equipment for business and government clients by operating a network of e-commerce marketplaces that enable buyers and sellers to transact in an efficient, automated environment offering across different product categories. The company has four reportable segments: GovDeals, Capital Assets Group (CAG), Retail Supply Chain Group (RSCG), and Machinio. It generates majority of its revenue from Retail Supply Chain Group (RSCG) segment which consists of marketplaces that enable corporations located in the United States and Canada to sell excess, returned, and overstocked consumer goods. Geographically, a substantial portion the company's revenue is generated from its business in United States.
About IMTX Immatics N.V.
Immatics NV is a biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.